Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 5/20 | 0.52 |
| ▸ | XDH | P47989 | 3/20 | 0.49 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.49 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | DHODH | Q02127 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21939124 | 0.87 | XDH (0.49) | ABCB1XDHSLC22A12CSNK2A1DHODH | |
| SCHEMBL16448844 | 0.86 | ABCB1 (0.48) | ABCB1CSNK2A1SYKGAA | |
| SCHEMBL4856552 | 0.84 | ALDH1A1 (0.54) | ABCB1XDHSLC22A12ALDH1A1MAPT | |
| SCHEMBL28607405 | 0.84 | PTPN11 (0.51) | XDHSLC22A12DHODHALDH1A1 | |
| SCHEMBL4282168 | 0.84 | FOS (0.50) | XDHSLC22A12DHODHALDH1A1TP53 | |
| SCHEMBL28820189 | 0.83 | ABCB1 (0.49) | ABCB1ALDH1A1MAPTTHRBGPR55 | |
| SCHEMBL26724900 | 0.83 | TSHR (0.47) | ABCB1CSNK2A1ALDH1A1MAPT | |
| SCHEMBL1641613 | 0.81 | TSHR (0.57) | CSNK2A1DHODHMAPT | |
| SCHEMBL6198908 | 0.81 | ALDH1A1 (0.59) | XDHSLC22A12DHODHALDH1A1MAPT | |
| SCHEMBL14066214 | 0.80 | PTGDR2 (0.60) | CSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104829756-A | Solid catalyst component for olefin polymerization, and preparation method and application thereof | CHINESE ACAD INST CHEMISTRY | 2015-08-12 | — | — | CN | disclosed |
| US-20090118169-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118169-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF | SP1, AP1G1, AP1M1 | ABCB1 942/4885XDH 1365/4885SLC22A12 784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.